Sanofi, Lonza JV Should Offer Pair Flexibility In Biologics Manufacturing

The pair's pact to build a biologics manufacturing site in Switzerland will allow Sanofi to expand or contract capacity usage in response to demand for its future biological therapies and give Lonza the option to pick up any eventual slack.